Dr. Tina Maria Mascarenhas, DO, MPH Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 289 Ireland Ave, Fort Knox, KY 40121 Phone: 502-624-9333 |
Dr. Kevin Christopher Reilly Sr., M.D. Radiology - Neuroradiology Medicare: Not Enrolled in Medicare Practice Location: 289 Ireland Ave, Ireland Army Community Hospital, Fort Knox, KY 40121 Phone: 502-624-9618 Fax: 502-624-0437 |
Thomas Paul Eberle Jr., M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 289 Ireland Ave, Ireland Army Community Hospital, Fort Knox, KY 40121 Phone: 502-624-9007 Fax: 502-624-0252 |
News Archive
Researchers from Chronix Biomedical and The University of Texas MD Anderson Cancer Center today announced that results from a pilot study demonstrating the utility of cell-free DNA (cfDNA) blood tests as a companion diagnostic for breast cancer patients are to be reported in a poster presentation titled "Modulation of breast cancer cell-free DNA with surgical resection" (Abstract #11060) at the American Society of Clinical Oncology Annual Meeting (ASCO 2013) being held from May 31 through June 4, 2013 in Chicago. The blood test detects cfDNA that is released into the blood stream by damaged and dying cancer cells.
The development of stem cell therapies to cure a variety of diseases depends on the ability to characterize stem cell populations based on cell surface markers.
A gene important in skin tanning has been linked to higher risk for testicular cancer in white men, according to a study led by scientists from the U.S. National Institutes of Health and the University of Oxford in England.
Breast-feeding reduces the risk for estrogen receptor-negative and progesterone receptor-negative breast cancer, according to a study conducted at Columbia University's Mailman School of Public Health.
Amgen and GlaxoSmithKline (GSK) today announced a collaboration in which the companies will share commercialization of Amgen's monoclonal antibody denosumab for postmenopausal osteoporosis (PMO) in Europe, Australia, New Zealand and Mexico once the product is approved in these countries.
› Verified 6 days ago